Kevin Talbot

25.8k citations

240 papers · 12.5k indexed · 1 hit paper · h-index 66

Genetics top 0.05%
- Neurogenetic and Muscular Disorders Research 122
Neurology top 0.05%
- Amyotrophic Lateral Sclerosis Research 146
- Parkinson's Disease Mechanisms and Treatments 55
- Neurological diseases and metabolism 19
Neurology top 0.5%
- Amyotrophic Lateral Sclerosis Research 146
- Parkinson's Disease Mechanisms and Treatments 55
- Neurological diseases and metabolism 19
Cellular and Molecular Neuroscience top 0.5%
- Genetic Neurodegenerative Diseases 20
Molecular Biology top 1%
- RNA modifications and cancer 35
- RNA Research and Splicing 31
- Prion Diseases and Protein Misfolding 14

Co-authors: Martin R. Turner Thomas H. Gillingwater Bradley J. Turner Olaf Ansorge Elizabeth Gray Lyndsay M. Murray Matthew C. Kiernan Alexander G. Thompson
Cited by: Genetics Neurology
Journals: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (19 papers)Human Molecular Genetics (18 papers)Journal of Neurology Neurosurgery & Psychiatry (16 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Kevin Talbot

231 papers receiving 12.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Kevin Talbot

Since Specialization

Citations

This map shows the geographic impact of Kevin Talbot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Talbot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Talbot more than expected).

Fields of papers citing papers by Kevin Talbot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Talbot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Talbot. The network helps show where Kevin Talbot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kevin Talbot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kevin Talbot Line = papers co-authored together Kevin Talbot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Basis of Cognitive and Behavioral Dysfunction in Amyotrophic Lateral Sclerosis Brain and Behavior ·Alexander Bampton,Caroline McHutchison,Kevin Talbot,Michael Benatar,Alexander G. Thompson,Martin R. Turner	2024	0
2	Women with epilepsy need choice, not diktats, when it comes to sodium valproate Pharmaceutical journal/The pharmaceutical journal ·邱强 Qiu Qiang,Uzmasaman Aejaz Chanderki,Kevin Talbot,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2023	1
3	Mutant GGGGCC RNA prevents YY1 from binding to Fuzzy promoter which stimulates Wnt/β-catenin pathway in C9ALS/FTD Nature Communications ·Zhefan Stephen Chen,Venkata Pawan Sriperumbuduri,Stephanie N. Taylor,Ruxandra Dafinca,Shaohong Peng,Kevin Talbot,Ho Yin Edwin Chan	2023	3
4	Aberrant dynein function promotes TDP-43 aggregation and upregulation of p62 in male mice harboring transgenic human TDP-43 Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·T A Kruse,W. I. Cho,David F. Gordon,Kevin Talbot,Majid Hafezparast	2023	2
5	C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9 Nature Communications ·Björn F. Vahsen,Ö. Ünal,Sarah F. Mahurt,Lucy Farrimond,Emily Carroll,Yinyan Xu,Kaitlyn M. L. Cramb,Rama Tamrakar,Jakub Scaber,Jon Martín Etxebeste,Ana Candalija,Carol J. Savage,Ruxandra Dafinca,Adrian M. Isaacs,Richard Wade‐Martins,Elizabeth Gray,Martin R. Turner,Sally A. Cowley,Kevin Talbot	2023	34
6	Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair Human Molecular Genetics ·Nidaa A. Ababneh,Jakub Scaber,Rowan Flynn,Andrew G. L. Douglas,Paola Barbagallo,Ana Candalija,Martin R. Turner,David Sims,Ruxandra Dafinca,Sally A. Cowley,Kevin Talbot	2020	52
7	The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Yang G,Arseniy Lavrov,Luis Garcia‐Gancedo,Jim Parr,Robert G. Hart,Joris Boulo,Christopher E. Shaw,Ammar Al‐Chalabi,Rachael Marsden,Martin R. Turner,Kevin Talbot	2020	17
8	Improving clinical trial outcomes in amyotrophic lateral sclerosis Nature Reviews Neurology ·Matthew C. Kiernan,Steve Vucic,Kevin Talbot,Christopher McDermott,Orla Hardiman,Jeremy M. Shefner,Ammar Al‐Chalabi,William Huynh,Merit Cudkowicz,Paul Talman,Leonard H. van den Berg,Thanuja Dharmadasa,Paul Wicks,C.M. Reilly,Martin R. Turner	2020	178
9	Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational Study JMIR mhealth and uhealth ·Luis Garcia‐Gancedo,Yang G,Arseniy Lavrov,Jim Parr,R G Hart,Rachael Marsden,Martin R. Turner,Kevin Talbot,Joris Boulo,Christopher E. Shaw,Ammar Al‐Chalabi	2019	41
10	Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction Neurobiology of Disease ·David F. Gordon,Ruxandra Dafinca,Jakub Scaber,Javier Alegre‐Abarrategui,Lucy Farrimond,Connor Scott,Daniel Biggs,Paul Bartolemea,Peter L. Oliver,Benjamin Davies,Olaf Ansorge,Richard Wade‐Martins,Kevin Talbot	2018	66
11	Trk receptor signaling and sensory neuron fate are perturbed in human neuropathy caused by Gars mutations Proceedings of the National Academy of Sciences ·James N. Sleigh,John M. Dawes,Steven J. West,Na Wei,Emily L. Spaulding,Aki Makkonen,Qian Zhang,Robert W. Burgess,M. Zameel Cader,Kevin Talbot,Xiang‐Lei Yang,David Bennett,Giampietro Schiavo	2017	57
12	Neurofilament light chainbreakdown → Neurology ·Ching‐Hua Lu,Corrie Macdonald‐Wallis,Elizabeth Gray,Neil Pearce,Axel Petzold,Niklas Norgren,Gavin Giovannoni,Pietro Fratta,Katie Sidle,Mark Fish,Richard W. Orrell,Robin Howard,Kevin Talbot,Linda Greensmith,Jens Kühle,Martin R. Turner,Andrea Malaspina	2015	390
13	Advances in motor neurone disease Journal of the Royal Society of Medicine ·Dirk Bäumer,Kevin Talbot,Martin R. Turner	2014	88
14	Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice Human Molecular Genetics ·James N. Sleigh,Stuart J. Grice,Robert W. Burgess,Kevin Talbot,M. Zameel Cader	2013	66
15	HspB8 mutation causing hereditary distal motor neuropathy impairs lysosomal delivery of autophagosomes Journal of Neurochemistry ·Jeanne P. Moon,Kanchan Phadwal,Bradley J. Turner,Peter L. Oliver,H. Lee,Anna Katharina Simon,Kevin Talbot,Vishwas R. Agashe	2011	47
16	Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations Neurology ·Dirk Bäumer,D. A. Hilton,Simon Paine,Martin R. Turner,James Lowe,Kevin Talbot,Olaf Ansorge	2010	148
17	Motor neuron disease : a practical manual Oxford University Press eBooks ·Kevin Talbot	2010	1
18	Candidate screening of the bovine and feline spinal muscular atrophy genes reveals no evidence for involvement in human motor neuron disorders Neuromuscular Disorders ·Nick Parkinson,Dirk Bäumer,W. Jacobi,Kevin Talbot	2008	5
19	Investigation of white matter pathology in ALS and PLS using tract‐based spatial statistics Human Brain Mapping ·Olga Ciccarelli,Timothy E.J. Behrens,Heidi Johansen‐Berg,Kevin Talbot,Richard W. Orrell,Robin Howard,Rita G. Nunes,David H. Miller,Paul M. Matthews,Alan J. Thompson,Stephen M. Smith	2008	118
20	Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene Neurology ·Paul A. James,M. Zameel Cader,F. Muntoni,Anne Marie Childs,Yanick J. Crow,Kevin Talbot	2006	68

About Kevin Talbot

Kevin Talbot is a scholar working on Genetics, Neurology and Medical Terminology, having authored 240 papers that have together received 12.5k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (146 papers), Neurogenetic and Muscular Disorders Research (122 papers), Parkinson's Disease Mechanisms and Treatments (55 papers), RNA modifications and cancer (35 papers), RNA Research and Splicing (31 papers), Genetic Neurodegenerative Diseases (20 papers), Neurological diseases and metabolism (19 papers) and Prion Diseases and Protein Misfolding (14 papers). The work is most often cited by research in Genetics (5.0k citations), Neurology (6.9k citations) and Neurology (1.4k citations). Kevin Talbot has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Martin R. Turner, Thomas H. Gillingwater, Bradley J. Turner, Olaf Ansorge, Elizabeth Gray, Lyndsay M. Murray, Matthew C. Kiernan, Alexander G. Thompson, Steven Knight and Dirk Bäumer. Their work appears in journals such as Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Human Molecular Genetics, Journal of Neurology Neurosurgery & Psychiatry, Neurology and Brain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact